患有法布里病和R356W GLA变异的患者的临床表现
Emanuele Monda1, Marta Rubino2, Eleonora Riccio3
1Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy; Institute of Cardiovascular Science, University College London, London, UK.
超罕见的R356W GLA变体在法布里病 (FD) 中呈现于成年期,主要是心脏问题,如左心室缩和不完全透. 这种变种似乎会导致晚期发病的FD,主要是心脏表现.
科学领域:
- 遗传学和罕见疾病.
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 费布里病 (FD) 是一种罕见的遗传性疾病.
- R356W GLA 变种是一种极为罕见的FD病因.
- 患有R356W GLA变异的成年患者的临床表现没有得到充分的记录.
研究的目的:
- 描述R356W GLA变体在患有法布里病的成年患者中的临床表型.
- 调查与这种变种相关的心脏和脏表现的患病率.
主要方法:
- 追溯性,观察性,纵向性队列研究.
- 包括连续诊断为FD携带R356W GLA变异的患者.
- 从基线到最后的随访收集临床,实验室和成像数据.
主要成果:
- 评估了36名患者 (6个家庭;67%女性;年龄41.1±15.9岁).
- 左心室缩 (LVH) 的患病率为31%,慢性病 (CKD) 的患病率为17%.
- 患有LVH的患者年龄较大,CKD患病率较高,心脏参数较差. 一名患者出现了先进的心房静脉阻塞,另一个患者患有需要透析的末期病.
结论:
- R356W GLA 变种可能会导致晚期发病的法布里病.
- 这种变种表现出不完全的穿透性.
- 在患有R356W GLA变异的患者中,主要观察到心脏表现.
更多相关视频
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
06:48Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
相关概念视频
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Lysosomal Hydrolases
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
